ResearcherStiftung CharitéNo recent work listed

Noreen Otto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5015742281. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2012: 2 papers

Papers 2

The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. Co-author DOI 10.1038/bjc.2011.521 ↗
Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. Co-author DOI 10.1111/j.1349-7006.2011.02140.x ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Petra M. Schulz · 2 shared papers, 2012 · strength 0.07
- Paper The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. DOI 10.1038/bjc.2011.521 ↗
- Paper Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. DOI 10.1111/j.1349-7006.2011.02140.x ↗
Bertram J. Wiedenmann · 2 shared papers, 2012 · strength 0.07
- Paper The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. DOI 10.1038/bjc.2011.521 ↗
- Paper Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. DOI 10.1111/j.1349-7006.2011.02140.x ↗
Katharina M Detjen · 2 shared papers, 2012 · strength 0.07
- Paper The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. DOI 10.1038/bjc.2011.521 ↗
- Paper Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. DOI 10.1111/j.1349-7006.2011.02140.x ↗
Arne Scholz Scholz · 1 shared paper, 2012 · strength 0.03
- Paper The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. DOI 10.1038/bjc.2011.521 ↗
Anja Rabien · 1 shared paper, 2012 · strength 0.03
- Paper Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. DOI 10.1111/j.1349-7006.2011.02140.x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.